Article

Fasting Insulin Levels and Cognitive Decline in Older Women without Diabetes

Department of Epidemiology/Biostatistics and Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.
Neuroepidemiology (Impact Factor: 2.48). 02/2008; 30(3):174-9. DOI: 10.1159/000126909
Source: PubMed

ABSTRACT Type 2 diabetes has been associated with an increased risk of dementia. To assess possible independent effects of insulin, we investigated the relation of insulin levels to cognitive decline in nondiabetic women.
Fasting plasma insulin levels were measured in mid-life in 1,416 nondiabetic Nurses' Health Study participants, who also completed cognitive testing that began 10 years later (current age: 70-75 years). Over 4 years, 3 assessments of general cognition, verbal memory, category fluency and attention were administered. Primary outcomes were the Telephone Interview for Cognitive Status (TICS) performance, the global score (average of all tests) and verbal memory (average of verbal recall tests). Linear mixed-effects models were used to calculate the association between insulin and cognitive decline.
Higher insulin levels were associated with a faster decline on the TICS and verbal memory. For analysis, batch-specific quartiles of insulin levels were constructed. Compared to the lowest quartile, adjusted differences in the annual rates of decline (with 95% CI values in parentheses) for the second, third and fourth quartiles were: TICS, -0.06 (-0.16, 0.03), -0.14 (-0.24, -0.04), and -0.09 (-0.19, 0.01) points (p trend = 0.04); verbal memory, -0.01 (-0.04, 0.02), -0.05 (-0.08, -0.02), and -0.02 (-0.05, 0.01) units (p trend = 0.02). These associations remained after multivariable adjustment.
Our study provides evidence for a potential role of higher fasting insulin levels in cognitive decline, possibly independent of diabetes.

Download full-text

Full-text

Available from: Michael Pollak, Sep 01, 2015
0 Followers
 · 
113 Views
 · 
46 Downloads
  • Source
    • "In the Nurses' Health Study (NHS), nondiabetic women with higher fasting insulin levels tended to have lower performance on global and verbal cognition. Furthermore, higher levels of fasting insulin were associated with faster rates of cognitive decline [16]. However, insulin levels were relatively low in this study indicating a potential role of even modestly elevated insulin concentrations. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Epidemiological studies suggest that being obese in midlife is a risk factor for cognitive decline and dementia in later life. Hyperinsulinemia is one of the most frequent endocrine features in overweight people which results in insulin desensitization. Thus, chronically high insulin levels have been identified as risk factor for dementia. Accordingly, chronically high insulin levels might be harmful for brain function. Furthermore, insulin and IGF-1-induced signaling is reduced in the brains of patients suffering from Alzheimer's disease (AD). Interestingly, studies in rodents suggest that reduced insulin receptor (IR) and insulin-like growth factor-1 receptor (IGF-1R) signaling decrease AD pathology, that is, β-amyloid toxicity. Data obtained in C. elegans indicate that the beneficial effect mediated via reduced IR/IGF-1R signaling might partially be induced via the forkhead-box O transcription factors (FoxO). In the mammalian brain, there are FoxO1, FoxO3a, and FoxO6 expressed. Surprisingly, high-fat diet specifically reduces the expression of FoxO3a and FoxO6 suggesting that IR/IGF-1 → FoxO-mediated transcription is involved in the pathogenesis of obesity-associated cognitive impairment. Therefore, the function of FoxO1 and FoxO3a has been investigated in animal models of Alzheimer's disease in detail. The current paper focuses on the role of IR/IGF-1 signaling and IR/IGF-1 → FoxO-mediated transcription for the pathogenesis of obesity-associated dementia.
    Current Gerontology and Geriatrics Research 05/2012; 2012:384094. DOI:10.1155/2012/384094
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper describes an activity by the Electric Power Research Institute (EPRI) to provide a handbook for guidance on design, verification and validation of digital upgrades to instrumentation and control systems. The handbook follows a layered design, with a hgh level handbook useful for managers, and supporting detail providing guidance for engineers. A classification approach is central for providing focused guidance for particular classes of applications. I. INTRODUCTION Nuclear utilities have embarked upon extensive programs to replace and upgrade their analog instrumentation and control (I&C) systems with digital technology. These new digital systems cover a wide range of applications, from safetycritical protection systems to non-safety control systems, and their implementations range from customized, turnkey computer systems to utility-integrated configurations of programmable logic controllers. In each case, the utility must address Micult issues of digital system and software quality. To support these utility activities, EPRI is developing a Handbook for Verification and Validation (V&V) of digital I&C systems. V&V is a systematic program of review and testing activities performed throughout the software life cycle. According to IEEE Standard 610.12-1990,
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Obesity is associated with increased risk for cardiovascular health problems including diabetes, hypertension, and stroke. These cardiovascular afflictions increase risk for cognitive decline and dementia, but it is unknown whether these factors, specifically obesity and Type II diabetes, are associated with specific patterns of brain atrophy. We used tensor-based morphometry (TBM) to examine gray matter (GM) and white matter (WM) volume differences in 94 elderly subjects who remained cognitively normal for at least 5 years after their scan. Bivariate analyses with corrections for multiple comparisons strongly linked body mass index (BMI), fasting plasma insulin (FPI) levels, and Type II Diabetes Mellitus (DM2) with atrophy in frontal, temporal, and subcortical brain regions. A multiple regression model, also correcting for multiple comparisons, revealed that BMI was still negatively correlated with brain atrophy (FDR <5%), while DM2 and FPI were no longer associated with any volume differences. In an Analysis of Covariance (ANCOVA) model controlling for age, gender, and race, obese subjects with a high BMI (BMI > 30) showed atrophy in the frontal lobes, anterior cingulate gyrus, hippocampus, and thalamus compared with individuals with a normal BMI (18.5-25). Overweight subjects (BMI: 25-30) had atrophy in the basal ganglia and corona radiata of the WM. Overall brain volume did not differ between overweight and obese persons. Higher BMI was associated with lower brain volumes in overweight and obese elderly subjects. Obesity is therefore associated with detectable brain volume deficits in cognitively normal elderly subjects.
    Human Brain Mapping 11/2009; 31(3):353-64. DOI:10.1002/hbm.20870 · 6.92 Impact Factor
Show more